Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

587 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease.
Ruemmele FM, Veres G, Kolho KL, Griffiths A, Levine A, Escher JC, Amil Dias J, Barabino A, Braegger CP, Bronsky J, Buderus S, Martín-de-Carpi J, De Ridder L, Fagerberg UL, Hugot JP, Kierkus J, Kolacek S, Koletzko S, Lionetti P, Miele E, Navas López VM, Paerregaard A, Russell RK, Serban DE, Shaoul R, Van Rheenen P, Veereman G, Weiss B, Wilson D, Dignass A, Eliakim A, Winter H, Turner D; European Crohn's and Colitis Organisation; European Society of Pediatric Gastroenterology, Hepatology and Nutrition. Ruemmele FM, et al. Among authors: veres g. J Crohns Colitis. 2014 Oct;8(10):1179-207. doi: 10.1016/j.crohns.2014.04.005. Epub 2014 Jun 6. J Crohns Colitis. 2014. PMID: 24909831 Free article.
Infliximab therapy for pediatric Crohn's disease.
Veres G, Baldassano RN, Mamula P. Veres G, et al. Expert Opin Biol Ther. 2007 Dec;7(12):1869-80. doi: 10.1517/14712598.7.12.1869. Expert Opin Biol Ther. 2007. PMID: 18034652 Review.
Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease.
Kiss LS, Szamosi T, Molnar T, Miheller P, Lakatos L, Vincze A, Palatka K, Barta Z, Gasztonyi B, Salamon A, Horvath G, Tóth GT, Farkas K, Banai J, Tulassay Z, Nagy F, Szenes M, Veres G, Lovasz BD, Vegh Z, Golovics PA, Szathmari M, Papp M, Lakatos PL; Hungarian IBD Study Group. Kiss LS, et al. Among authors: veres g. Aliment Pharmacol Ther. 2011 Oct;34(8):911-22. doi: 10.1111/j.1365-2036.2011.04827.x. Epub 2011 Aug 24. Aliment Pharmacol Ther. 2011. PMID: 21883326 Free article.
Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009.
Lakatos PL, Golovics PA, David G, Pandur T, Erdelyi Z, Horvath A, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Veres G, Lovasz BD, Szathmari M, Kiss LS, Lakatos L. Lakatos PL, et al. Among authors: veres g. Am J Gastroenterol. 2012 Apr;107(4):579-88. doi: 10.1038/ajg.2011.448. Epub 2012 Jan 10. Am J Gastroenterol. 2012. PMID: 22233693
Diagnostic yield of upper endoscopy in paediatric patients with Crohn's disease and ulcerative colitis. Subanalysis of the HUPIR registry.
Kovacs M, Muller KE, Arato A, Lakatos PL, Kovacs JB, Varkonyi A, Solyom E, Polgar M, Nemes E, Guthy I, Tokodi I, Toth G, Horvath A, Tarnok A, Tomsits E, Csoszánszky N, Balogh M, Vass N, Bodi P, Dezsofi A, Gardos L, Micskey E, Papp M, Szucs D, Cseh A, Molnar K, Szabo D, Veres G; Hungarian IBD Registry Group (HUPIR). Kovacs M, et al. Among authors: veres g. J Crohns Colitis. 2012 Feb;6(1):86-94. doi: 10.1016/j.crohns.2011.07.008. Epub 2011 Aug 23. J Crohns Colitis. 2012. PMID: 22261532
Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's disease.
Shaoul R, Sladek M, Turner D, Paeregaard A, Veres G, Wauters GV, Escher J, Dias JA, Lionetti P, Staino A, Kolho KL, de Ridder L, Nuti F, Cucchiara S, Sheva O, Levine A; ESPGHAN Porto IBD Group. Shaoul R, et al. Among authors: veres g. Inflamm Bowel Dis. 2012 Aug;18(8):1493-7. doi: 10.1002/ibd.21875. Epub 2012 Jan 24. Inflamm Bowel Dis. 2012. PMID: 22275268
Rapid test for fecal calprotectin levels in children with Crohn disease.
Kolho KL, Turner D, Veereman-Wauters G, Sladek M, de Ridder L, Shaoul R, Paerregaard A, Amil Dias J, Koletzko S, Nuti F, Bujanover Y, Staiano A, Bochenek K, Finnby L, Levine A, Veres G. Kolho KL, et al. Among authors: veres g. J Pediatr Gastroenterol Nutr. 2012 Oct;55(4):436-9. doi: 10.1097/MPG.0b013e318253cff1. J Pediatr Gastroenterol Nutr. 2012. PMID: 22411269
Low mannose-binding lectin (MBL) is associated with paediatric inflammatory bowel diseases and ileal involvement in patients with Crohn disease.
Kovacs M, Papp M, Lakatos PL, Jacobsen S, Nemes E, Polgar M, Solyom E, Bodi P, Horvath A, Molnar K, Szabo D, Cseh A, Muller KE, Dezsofi A, Arato A, Veres G. Kovacs M, et al. Among authors: veres g. J Crohns Colitis. 2013 Mar;7(2):134-41. doi: 10.1016/j.crohns.2012.03.008. Epub 2012 Apr 13. J Crohns Colitis. 2013. PMID: 22504031
587 results